Company Overview

Update
Founded:
2011
Founders:
Punit Dhillon
Headquarters:
San Diego, CA
IPO:
Went Public on Jan 1, 2000
Stock:
OTCMKTS:ONCS
Categories:
Health Care

OncoSec Medical, a biotechnology company, develops treatments for advanced stage skin cancer patients.

Description

Update

OncoSec™ Medical Incorporated (OTCBB: ONCS) is an advanced-stage biomedical company focused on the development of novel therapeutic oncology products. Our mission, above all, is to improve the quality and performance of treatments for patients suffering from solid tumor cancers. This is driven by our unwavering commitment to improving the quality of lives of cancer patients through the use of innovative research and the advancement of new “ElectroOncology™” therapies based on our proprietary OncoSec™ Medical System (OMS). OncSec’s™ core technology is an untapped delivery system, which applies short electric impulses to a tumor causing transient pores to open in the cellular membrane allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS Electroporation. Using OMS Electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells... See More

Current Team (6)

Update

Board Members and Advisors (3)

Update

Funding Rounds (2) - $15M

Update

Offices/Locations (1)

Update
  • Office

    9810 Summers Ridge Road

    Suite 110

    San Diego, CA 92121

    USA

Images (1)

Update
  • 1c1466b5257ee4ee0a1a55dd83e101a0